This site is intended for healthcare professionals only
LoginRegister
Health Ministry Reduces Clinical Trial Approval Time from 90 to 45 DaysSuven Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead...
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and DevicesGovt Panel Proposes Separate Licensing System for Bulk Drugs and Excipients Wholesalers
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusAlembic Pharma wins USFDA nod for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension
Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in ChinaBoehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in...
GSK Exdensur wins USFDA approval for severe asthmaGSK risvutatug rezetecan gets USFDA Orphan Drug Designation for lung cancer
AIOCD Hails Union Budget 2026 as Patient-Centric Roadmap for Pharma GrowthKerala Blocks 17 Faulty Medicines Including Rabeprazole, Ciprofloxacin After Counterfeit Seizure
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTracIndian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac
CDSCO Panel Flags Gaps in Serum Institutes rBCG Vaccine Data, Calls for Stronger TrialCDSCO Panel Flags Gaps in Serum Institute's rBCG Vaccine Data, Calls for Stronger Trial
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesBharat Biotech, Aurobindo and Hetero sign multi crore investment deals in Telangana
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer AskBio receive Pioneering Regenerative Medical Product Designation for gene therapy programs...
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark
Novo Nordisk concludes acquisition of Akero TherapeuticsNovo Nordisk concludes USD 4.7 billion acquisition of Akero Therapeutics
X